On the recordJuly 26, 2022
Mr. Speaker, I rise in support of H.R. 623, the ``Gabriella Miller Kids First Research Act 2.0.'' As Chairwoman of the House Health Subcommittee, I'm proud to have advanced this bipartisan bill and I'm pleased to support it on the Floor today. Gabriella Miller Kids First Research Act 2.0 reauthorizes the Gabriella Miller Kids First Pediatric Research Program and nearly doubles critical funding for pediatric cancer research to $25 million each year for the next five years. Pediatric cancer is the number one disease killer for children in the U.S., claiming roughly 1,800 lives every year. Children with certain birth defects have an increased risk of pediatric cancer, yet the genetic relationship between these conditions is still poorly understood. First launched in 2014, the Gabriella Miller Kids First Pediatric Research Program connects the dots between birth defects and childhood cancers, with the hope of fostering data-driven solutions for personalized treatments. This program is named in honor of Gabriella Miller, a fierce advocate for childhood cancer research who died of brain cancer at the young age of 10. Ellyn Miller, Gabriella's mother, when testifying at my Subcommittee last year, said that Gabriella told her that she wanted elected officials to ``stop talking and start doing.'' I urge my colleagues to stop talking and start doing by passing this important bill. The SPEAKER pro tempore. The question is on the motion offered by the gentleman from New Jersey (Mr.…





